Rare Disease Summit is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Ray Takigiku, PhD
Founder and CEO at Bexion Pharmaceuticals

Agenda Sessions

  • First-in-Human, First-in-Class Phase 1a Study of BXQ-350 for Solid Tumors and Gliomas